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Epidemiologic and clinical studies over the last decade have identified 
individuals with increased plasma insulin concentrations in association with 
other disorders including hypertension, obesity, dyslipidemia and 
hyperglycemia. Hyperuricemia and renal dysfunction are sometimes included 
with these symptoms. (Modan et al, 1985; Haffner et al, 1988; Reaven, 
1995). 
Insulin resistance with compensatory hyperinsulinemia has been proposed as 
the common causative mechanism that links these conditions into a common 
syndrome referred to as the insulin resistance syndrome (Fuh et al, 1987; 
Reaven, 1988; De Fronzo and Ferrannini, 1991). 
Ferranini et al (1987) suggested that insulin resistance is associated with 
essential hypertension and is independant of other factors. A number of 
epidemiologic studies have also demonstrated the presence of 
hyperinsulinemia both in the fasting and post-prandial state in normal weight 
individuals with essential hypertension (Modan et al, 1985; Pollare et al, 
1990; Reaven, 1991(a). These findings are consistent with one of the three 
following possibilities: 
1. Insulin resistance-hyperinsulinemia precedes the onset of high blood 
pressure and contributes to its pathogenesis. 
2. Hypertension precedes the onset of insulin resistance and contributes 
to its pathogenesis through metabqlic and/or hemodynamic alterations. 
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3. Insulin resistance and hypertension are inherited as separate traits 
that develop in a parallel but in dependant manner. 
The use of a genetic model of hypertension can help to further elucidate the 
relationship between insulin resistance and hypertension. In fact, if 
hypertension or some related aspect is responsible for the development of 
insulin resistance, one should be able to demonstrate impaired insulin-
mediated glucose metabolism in animal models of hypertension. 
The reported results on genetic models of hypertension have been 
contradictory. Some authors reported that spontaneously hypertensive rats 
are insulin resistant and hyperinsulinemic compared to their control Wistar 
Kyoto rats (Mondon and Reaven, 1988; Reaven, 1991). Other authors 
could not support these findings in spontaneously hypertensive rats or in 
Milan genetic hypertensive rats (Buchanan et al, 1992; Frontoni et al, 
1992). The only results reported thus far in the Dahl genetic model of 
hypertension were based on serum glucose and insulin determination in 
response to an oral glucose load (Kotchen et al, 1991) or in vitro on glucose 
transport in isolated adipocytes (Reaven et al, 1991 ). 
These important findings however, are based on surrogate measurements of 
insulin action and not on currently accepted in vivo standard methods. 
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OBJECTIVES 
The objectives of the present study were: 
To establish to what extent features of the insulin resistance syndrome 
establish themselves in the Dahl salt sensitive rat on feeding a normal/ 
high salt diet. 
To evaluate in vivo glucose metabolism and insulin sensitivity in the 
Dahl genetic salt-sensitive model of hypertension by using the eugly-
cemic clamp technique, the best available standard method. 
To determine if there is an association between hypertension, salt-
sensitivity and insulin sensitivity in the same model. 
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LITERATURE SURVEY 
1.1 Essential Hypertension 
Essential hypertension is a condition in which blood pressure levels are 
continuously elevated above predetermined cut off points and for which no 
established endocrine or renovascular cause has been identified. The cut off 
points for mild moderate and severe hypertension have been defined by the 
increases in atherosclerotic cardiovascular disease risk found in various 
community studies (Modan and Halkin, 1991). Hereafter hypertension will 
refer to essential hypertension. 
Given the central role of hypertension in the pathogenesis of both coronary 
heart disease and stroke, the World Health Organization has expressed 
concern over the "second wave" epidemic of cardiovascular disease that is 
now sweeping through the developing countries and the former socialist 
republics (Guidelines Subcommittee, WHO, 1999). 
Haemodynamic studies have shown two distinct hypertensive profiles. The 
first, termed neurogenic or borderline hypertension is characterized by 
increased blood volume and cardiac output with total peripheral resistance 
in the normal or slightly elevated range. The other called nonneurogenic or 
established hypertension has normal cardiac output, contracted blood volume 
and increased total peripheral resistance. It has been postulated that 
neurogenic hypertension evolves into the more severe nonneurogenic type but 
it is also possible that the two patterns represent two types of hypertension 
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with different etiologies. The neurogenic type is more prevalent and is 
associated with atherogenic risk factors like hyperinsulinemia, insulin 
resistance, dyslipidemia and obesity (Modan and Halkin, 1991 ). 
1.1.1 Elements of blood pressure regulation 
Arterial blood pressure can be defined as the product of cardiac output times 
total peripheral resistance. It is continuously monitored by baroreceptors in 
the carotid sinus and aortic arch which transmit their information to the 
central nervous system. The vasomotor centre in turn regulates cardiac 
output, peripheral vascular resistance and the efferent sympathetic tone . In 
addition as a slower response, renal renin secretion is increased via the 
activation of B-adrenergic receptors in the kidney induced by local 
noradrenaline release . Renin release, via angiotensin I (Ang I) leads to the 
formation of Ang II which increases thirst and salt appetite . In high 
physiological concentrations . (50-100 pmolll), Ang II directly increases 
peripheral vascular resistance and indirectly increases neurotransmitter 
release by a presynaptic action at adrenergic nerve endings . Another 
important action of Ang II is to stimulate the release of aldosterone which 
stimulates reabsorption of sodium and water in the kidneys . 
Atrial natriuretic factor released by the cardiac atria in response to an 
increase in wall tension and heart rate is a further important component of 
blood pressure regulation. This hormone, by a number of actions decreases 
arterial blood pressure and also inhibits aldosterone secretion. 
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Noradrenaline, Ang II and aldosterone all increase sodium and water 
reabsorption in the kidney leading to an expansion in extracellular volume 
and a rise in blood pressure. The kidney responds by an increase in salt and 
water output following an increase in arterial pressure that is independant of 
neuronal or humoral factors . This pressure diuresis shows that arterial 
pressure, besides its role in organ perfusion, also supports the body' s fluid 
balances (Osswald and Miihlbauer, 1995). In recent years, researchers 
have established the importance of endothelial vasoactive paracrine factors 
namely nitric oxide, prostacyclin and the endothelins on arterial vascular tone. 
Ultimately, a stable arterial pressure will depend on collective interactions 
between the endothelial paracrine pathway, cardiovascular and renal factors. 
(Shah, 1996). 
1.2. Salt Sensitivity 
A number of investigations have implicated sodium intake in the 
pathogenesis of hypertension (Tobian, 1995). Epidemiological studies show 
that in a given population, some individuals exhibit an increase in arterial 
blood pressure in response to excess dietary salt. These are referred to as 
the salt-sensitive group. The group that remains free of the pressor effect of 
salt is called the salt-resistant or non-salt sensitive group. Similarly in 
hypertensives, the salt sensitives will experience a significant rise in blood 
pressure when switching from a low-salt to a high-salt diet compared to the 
salt resistant hypertensives who will experience a minimal change in blood 
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pressure (Tobian, 1995). Salt sensitive hypertension is estimated to occur 
in 60% of the hypertensive population ·· and is more prevalent in Black 
Africans than in Whites (Luft et al, 1991). Currently, the underlying 
mechanisms of salt sensitivity are not well understood. Hyperinsulinemia, 
insulin resistance, altered renal haemodynamics, alterations in cellular sodium 
and calcium metabolism, low dietary mineral intake and elevated activities of 
Na+ /K+ 12c1- erythrocyte cotransport have been suggested to contribute to 
salt-sensitivity in susceptible individuals (Lluch et al, 1996). 
1.3. Insulin Resistance 
Insulin is a phylogenetically ancient hormone that has a variety of effects on 
various cell types. Its actions on glucose, lipid and protein metabolism are 
essential for life. Although insulin is central for intermediary metabolism, its 
chief control is exerted over the glucose system. For any amount of insulin 
secreted by the pancreas, the biological response of a given effector is 
dependant on its insulin sensitivity. Insulin resistance is customarily referred 
to in terms of the effects of a given amount of insulin on glucose uptake, that 
is, its effects on glucose metabolism only and not in reference to its other 
functions (Ferrannini and Mari, 1998). Insulin resistance can be defined as 
a state where there is hyperinsulinemic response to glucose administration 
accompanied by impaired or decreased glucose utilization (Sharma et al, 
1991 ~ Ferrannini and Mari, 1998). At its simplest, elevated plasma insulin 
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at the same time as normal fasting blood glucose level or a nse m 
postprandial insulin levels may reflect insulin resistance. 
For most hormones, regulation is provided mainly by changes in their 
secretory rates and under normal conditions their degradation is constant at 
a value typical for each hormone. Insulin is exceptional in that its action can 
also be regulated through target tissue sensitivity to its action. The 
coordination between insulin availability (B-cell function) and insulin need 
(tissue responsiveness) maintains plasma glucose within a narrow range. The 
feedback operates in the obese and elderly where insulin secretion rises to 
accommodate decreased tissue sensitivity and in physically trained 
individuals in whom insulin secretion falls as tissue sensitivity to the 
hormone increases (Berne and Levy, 1993). Insulin resistance is a 
widespread phenomenon both in physiological and in pathophysiological 
states. Puberty and pregnancy are associated with selective insulin 
resistance where an increase in insulin secretion facilitates amino acid uptake 
for tissue growth, while diabetes, obesity and hypertension are disease states 
associated with insulin resistance. 
Insulin mediated glucose uptake is therefore determined by tissue sensitivity 
to insulin and by the rate of glucose and insulin delivery via blood flow. The 
degree of insulin resistance will be determined by the relative contribution 
of each (Ferrannini and Mari, 1998). 
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1.3.1 Haemodynamic Hypothesis of Insulin Resistance 
Julius et al (1991) proposed the haemodynamic hypothesis of insulin 
resistance in skeletal muscles. It was suggested that structural vascular 
changes due to an increased proportion of fast (Type II) versus slow (Type 
I) muscle fibres and a decreased number of capillaries would decrease 
skeletal muscle blood supply. The subsequent reduced nutritional flow would 
limit the diffusion of insulin and substrates from the intravascular space to 
the target cell surface, thereby causing insulin resistance in skeletal muscles. 
Since skeletal muscle constitute 30% to 40% of the body mass, insulin 
resistance here is a major determinant of whole body insulin resistance. 
1.3.2 The Insulin Receptor and Insulin Resistance 
The insulin receptor is a transmembrane glycoprotein found in the plasma 
membrane of many cell types . The initial step in insulin action is the binding 
of insulin to the extracellular subunit of the insulin receptor (Figure 1 ). The 
transmembrane and cytoplasmic B subunit is a tyrosine-specific protein kinase 
that is activated after insulin binding and undergoes autophosphorylation. 
Subsequently, the activated insulin receptor kinase phosphorylates in cascade 
fashion intracellular substrates which ultimately leads to the metabolic effect 
of the hormone. This includes the movement of glucose transporters that 
facilitate glucose entry and the activation or deactivation of target enzymes 
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of glucose metabolism via phosphmylated protein kinases and phosphatases 
(Berne and Levey, 1993). 
In addition to altered tissue sensitivity or reduced blood flow, decreased 
insulin sensitivity may occur for a number of reasons, including defects in 
insulin binding caused by reduced receptor number or affinity, defects in 
signal transduction involving receptor autophosphorylation and tyrosine 
kinase activity or postreceptor defects at the level of substrates of 
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protein kinases and phosphatases, which in tum activate or 
deactivate target enzymes of glucose metabolism by phospho-
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ger.) By still undefined mechanisms, a transcription factor(s) 
is generated that stimulates or represses gene transcription 
through an insulin response element ~ IRE) in DNA molecules . 
Also independently potassium, magnesium. and phosphate 
entries into the cell are facilitated. 
Figure 1: Mechanism of insulin action on cells (from Berne and Levy, 
1993) 
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1.3.3 Altered target cell calcium ion (Ca2+) concentration as 
a cause of Insulin Resistance 
Genetically induced elevations in intracellular Ca2+ can result in insulin 
resistance in skeletal muscle and adipose tissue. Increased intracellular Ca2+ 
play a role in insulin signal transduction but elevations beyond an optimal 
range results in a loss of signal transduction. Elevated Ca2+ may contribute 
to insulin resistance by inhibiting the dephosphorylation of the insulin 
sensitive glucose transporter (Glut 4), and possibly other insulin-sensitive 
substrates, and thereby decreasing its activity. At this stage it is not clear to 
what extent increased intracellular Ca2+ contributes to insulin resistance 
(Zemel, 1995). 
1.4. Reaven's Hypothesis and the Insulin Resistance Syndrome 
Since the initial report 33 years ago of a disproportionately high plasma 
insulin concentration in hypertensive patients in response to glucose 
ingestion, many recent studies have also shown that hypertensive individuals 
are insulin resistant and hyperinsulinemic (Modan et al, 1985; Ferrannini et 
al, 1987; Reaven, 1988; De Fronzo and Ferrannini, 1991). Reaven (1988) 
hypothesised that resistance to the glucoregulatory effects of insulin and 
hyperinsulinemia may play a role in the development of a constellation of 
abnormalities (glucose intolerance, obesity, dyslipidemia and hypertension) 
known as the insulin resistance syndrome, the metabolic syndrome or 
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syndrome x. Because of its relevance to the present study, features of the 
hypothesis will be elaborated below. 
1.4.1 Pathophysiology of Insulin Resistance 
There are large variations in the ability of insulin to stimulate glucose uptake 
among individuals with normal glucose tolerance. Insulin resistance is not 
a common feature only in those who are glucose intolerant or with non-
insulin-dependant diabetes mellitus (NIDDM). It is estimated that 25o/o of the 
apparently healthy population have the same unspecified defect in insulin 
action as those who are glucose intolerant or with NIDDM (Reaven, 1995). 
1.4.2 Hyperinsulinemia and the Pathogenesis of Insulin Resistance 
In insulin resistance, the level to which glucose tolerance will deteriorate 
depends on the magnitude of loss of in vivo peripheral insulin action and the 
ability of the pancreatic B cells to compensate for this defect. In an effort to 
maintain plasma glucose levels between 4,5 mmol/Q to 7,8mmol/Q, the 
pancreatic cells will try to secrete whatever amount of insulin is required to 
maintain the ambient plasma glucose level. The more resistant the 
individual, the greater will be the compensatory hyperinsulinemia. If the B 
cell feedback cannot sustain the compensatory "philanthropic" effort, plasma 
glucose concentrations will begin to rise, leading to a series of events that 
-_ 
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culminate in prediabetes and finally NIDDM. Insulin resistant individuals 
who have normal or near normal glucose tolerance are hyperinsulinemic 
compared to insulin sensitive controls. It is the increased B cell secretion that 
permits them to overcome the defect in insulin action. This "homeostatic 
victory" is accompanied by a state of chronic hyperinsulinemia which can 
"hardly be called benign." It is the pathophysiological consequences of 
insulin resistance and/or chronic hyperinsulinemia that may manifest itself as 
the insulin resistance syndrome after a period of several years (Reaven, 
1995). The clinical implication of this syndrome is that any abnormality 




























Figure 2. Proposed relationships in the Insulin Resistance Syndrome. PAl-1, 
plasminogen activator inhibitor; VLDL, very low density lipoprote.in; HDL, high 
density lipoprotein (from Reaven, 1995) 
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1.4.3 Characteristics of the Insulin Resistance Syndrome 
In Figure 2 Reavens "mechanistic" hypothesis (Brown et al, 1997) is 
presented. It is a unified approach which attempts to explain the clustering 
of atherogenic risk factors which arise from a primary metabolic 
disturbance featuring insulin resistance and hyperinsulinemia. Insulin plays 
a central role in lipoprotein metabolism that is not affected by resistance to 
insulin mediated glucose disposal. The mechanism by which insulin 
resistance leads to dyslipidemia has not been completely characterized. 
There is good evidence to suggest that two of the ways in which 
hyperinsulinemia elevates triglycerides are through enhanced hepatic very 
low density-lipoprotein (VLDL) synthesis and through decreased VLDL 
clearance. An increased rate of degradation of apoprotein AI (the major 
lipoprotein in high-density lipoprotein (HDL) cholesterol) is believed to be 
a major cause for the reduced level of HDL cholesterol observed in many 
insulin resistant subjects. Although low density lipoprotein (LDL) cholesterol 
levels may not be significantly elevated in individuals with the insulin 
resistance syndrome, recent studies have shown that there may be 
disturbances in LDL composition. A sigilificant association has been shown 
between plasma insulin concentration and the presence of relatively smaller 
more dense LDL particles in individuals with insulin resistance. The small 
dense LDL might result from the altered VLDL metabolism already discussed 
(Howard, 1993). 
Elevated plasminogen-activator-inhibitor 1 (P Al-1) is also a feature of this 
cluster and is associated with deficient fibrinolysis. PAI- I is closely 
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associated with plasma triglyceride concentration but a direct relationship 
with insulin resistance still has to be defined (Reaven, 1995). Nevertheless, 
this feature has unfavourable effects on the blood coagulation and 
fibrinolytic system and predisposes the insulin resistant individual to 
thrombosis and atherosclerosis. 
Elevated uric acid levels are also a feature in patients displaying features of 
the insulin resistance syndrome. This increase is believed to arise from a 
shift in glucose metabolism to the pentose monophosphate shunt which leads 
to increased purine synthesis and increased uric acid or from decreased 
renal excretion of urate (Modan and Halkin, 1991 ; Puig and Ruilope, 1999). 
The proposed role of insulin resistance and hyperinsulinemia m the 
pathogenesis of hypertension is discussed separately below. 
1.5. Insulin Resistance and Hyperinsulinemia in the Regulation of Blood 
Pressure 
Almost 16-40% nonobese hypertensive patients appear to be insulin resistant 
and hyperinsulinemic and over 50% of insulin resistant hypertensives display 
the cluster of cardiovascular risk factors of the insulin resistance syndrome. 
Although the association between insulin resistance and hypertension may 
vary among different population, it is generally believed that insulin 
resistance has an important role in the pathogenesis of hypertension in the 
majority of populations (Lithell, 1995; Lind et al, 1995; Kotchen, 1996). 
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Reaven' s hypothesis proposes a common causative mechanism that links 
hypertension pathologically with disordered carbohydrate and lipoprotein 
metabolism. It may also e"''Plain why lowering of blood pressure alone does 
not necessarily decrease the risk of coronary heart disease. It must also be 
noted that the relationship between insulin resistance, hyperinsulinemia and 
hypertension exists even in the absence of overt glucose intolerance and 
obesity (Ferrannini et al, 1987). Hypertension has often been described as an 
insulin resistant state and it has been suggested that insulin resistance may 
somehow be related to the fundamental determinants of blood pressure. 
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Figure 3. The pathogenesis of insulin resistance, hyperinsulinemia and hypertension (adapted from Edelson and Sowers, 
1993). PGl2, Prostaglandin 12, PGE2 , Prostaglandin E2 
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1.6 Insulin Resistance and the role of insulin in hypertension 
With reference to Figure 3, the etiology of hyperinsulinemia in hypertension 
is thought to be the consequence of a compensatory increase in pancreatic 
B cell secretion as a response to decreased peripheral (skeletal muscle) insulin 
mediated glucose utilization. Hyperinsulinemia could also be enhanced due 
to reduced metabolic insulin clearance rate which could result in insulin 
remaining in the circulation for a longer period of time (Lender et al, 1997). 
The consequences by which insulin resistance/ hyperinsulinemia could result 
in hypertension are discussed below. 
1.6.1 Enhanced Renal Sodium Retention 
Insulin resistance and or acute hyperinsuline~ia can result in chronic 
sodium retention. Insulin can enhance renal sodium uptake both directly 
through stimulating Na+K+-ATPase activity in the proximal tubules and 
indirectly through stimulating the sympathetic nervous system, augmenting 
angiotensin II mediated aldosterone production and by altering the secretion 
of atrial natriuretic peptide (Edelson and Sowers, 1993). It has been also 
suggested that an elevated glomerular filtration fraction associated with 
insulin resistance may also favour sodium and water retention by the 
kidneys (Dengel et al, 1996). Because of the Na+ retaining effects of both 
insulin and insulin resistance, these states may be critical for the pathogenesis 
of salt sensitivity in essential hypertension. In support of this possibility, 
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studies performed on both normotensive and hypertensive subjects have 
demonstrated an association between salt sensitivity and insulin resistance 
(Sharma et al, 1991 ; Donovan et al, 1993; Zavaroni et al, 1995; Galetti et 
al, 1997). 
1.6.2 Activation of the Sympathetic Nervous System 
Acute hyperinsulinemia can activate the sympathetic nervous system. This 
causes the release and elevation of noradrenaline and other vasoconstrictor 
hormones, increased cardiac output due to sympathetic inotrophic and 
chronotrophic effects on the heart and an increase in renal and splanchnic 
blood flow (Modan and Hallcin, 1991 ). This combined with or independant 
of renal effects exerts a strong pressor effect on the cardiovascular system. 
1.6.3 Changes in vascular structure and reactivity 
Insulin and insulin-like growth factors are mitogens . capable of stimulating 
smooth muscle proliferation. Hyperinsulinemia could result in vascular 
smooth muscle hypertrophy, narrowing of the lumen of resistance vessels 
and ultimately the development of hypertension. Insulin could also directly 
enhance vascular reactivity to both noradrenaline and angiotensin II (Modan 
and Halkin, 1 991 ) . 
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1.6.4 Modulation of Transmembrane Electrolyte Pumps and Ion Transport 
Insulin is known to have a significant effect on several transmembrane ion-
exchange systems including Na+, K+ - A TPase, Ca2+, Mg2+ - A TPase and Na+ I
H+ exchanger. Hyperinsulinemia may be responsible for intracellular cation 
imbalances in vascular tissues. One of the well-described cellular actions 
of insulin is the stimulation of Na+, K+ - ATPase activity. Based on the 
exchange of three intracellular potassium ions with two extracellular sodium 
ions, stimulation of Na+,K+- ATPase will result in hyperpolarization of the 
cell membrane. In vascular smooth muscle cells this will trigger the closure 
of voltage dependant Ca2+ channels resulting in decreased intracellular Ca2+ 
concentration. This will lead to relaxation of the smooth muscle cells and 
hence vasodilation of the vascular bed. Na+ K+ - ATPase is also located in 
endothelial cells in which hyperpolarization will lead to a Ca2+ influx 
because of the increased electrogenic driving force (calcium channels in 
endothelial cells are voltage independent) . The increase in cytosolic Ca2+ 
concentration will stimulate endothelial synthesis and release of nitric oxide. 
Insulin mediated vasodilation therefore occurs via the Na+ K+ - ATPase pump 
and also via nitric oxide dependent vasodilation. In insulin resistant tissues 
these actions of insulin may be blunted leading to an absence of insulin 
induced vasodilation, increased vascular tone and increased reactivity of 
vascular smooth muscles all contributing to an increase in blood pressure 
(Weidmann et al 1995; Tack et al, 1996). Accordingly, vascular smooth 
muscle insulin resistance rather than hyperinsulinemia may result in 
hypertension. Further, on one hand it appears that insulin resistance in 
skeletal muscle and adipose tissue may occur due to increased intracellular 
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Ca2+ whereas on the other hand insulin resistance causes disordered 
regulation of vascular smooth muscle intracellular Ca2+ and increases in 
blood pressure (Zemel, 1995). 
1.6.5 Effects of Sympathetic Activity on Skeletal Muscle Insulin 
Resistance 
While the haemodynamic hypothesis is used to explain the cause of insulin 
resistance in skeletal muscle, sympathetic hyperactivity due to 
hyperinsulinemia itself could cause haemodynamic and structural changes in 
peripheral vessels thereby initiating or further aggravating insulin resistance. 
There is therefore also a possibility of insulin resistance being secondary to 
abnormal sympathetic and vascular mechanisms of skeletal muscles in 
hypertension. 
Increased sympathetic activation by itself could decrease blood flow and 
initiate changes in cellular uptake of glucose in skeletal muscle. Increased 
adrenergic tone is lrnown to be associated with the development of 
hypertrophy of vessel walls and possible vascular rarefaction. A decrease 
in nutritional supply to skeletal muscle due to reduced vascular function 
and/or a decrease in the number of capillaries could therefore contribute to 
the decreased glucose uptake seen in hypertension. 
Skeletal muscles consists of slow twitch red fibres (Type 1) which contain 
myoglobin., have a high oxidative - low glycolytic capacity, a high insulin 
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binding, a high basal glucose uptake, a high insulin sensitivity and a rich 
capillary supply. The fast twitch white (Type II) consist of a group 11-b that 
have opposite characteristics to the slow twitch, that is a high glycolytic - low 
oxidative capacity and a low capillary density. 
The group Ila have an intermediate speed of contraction, metabolic 
characteristics and capillary density when compared to the other two groups. 
Prolonged sympathetic stimulation can cause a transition in the ratio of slow 
to fast twitch fibres as seen in hypertension (Julius et al, 1991 ). 
1.6.6 Vasculopathy · The Proximal Pathogenic Event in Hypertension 
Vasculopathy, a dysfunction in the form of inappropriate vasoconstriction and 
structural alterations like arterial narrowing and stiffness due to a~normal cell 
proliferation and atherosclerosis is seen both in hypertension and NIDDM. 
Insulin appears to be one of a mosaic of factors contributing to this 
vasculopathy either by direct action on blood vessels themselves or in part 
through the associated metabolic abnormalities like hyperglycemia, 
hypertension and dyslipidemia (Weidmann et al, 1995). It has been 
suggested that in certain populations, insulin resistance may be an 
independent cause of atherosclerosis and both may share common roots 
(Taegtmeyer, 1996). 
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1. 7 Summary . Insulin Resistance, Hyperinsulinemia and Hypertension 
Insulin resistance and hyperinsulinemia have been correlated with 
hypertension, dyslipidemia and glucose intolerance which appear as a 
constellation of cardiovascular risk factors . Hypertension has been termed 
as an insulin resistant state with the skeletal muscles being identified as the 
major site of insulin resistance (Reaven, 1995). 
Hyperinsulinemia has effects on tissue that are not usually considered as 
insulin targets (Sechi, 1999). Effects like activation of renal sodiwn 
reaborption, increased sympathetic stimulation, modulation of 
transmembrane cation transport and the promotion of vascular hyper-
reactivity are all hypothetical contributions to the pro-hypertensive actions 
of insulin (Sechi, 1999). 
Evidence also points to the role of insulin as a hypotensive hormone since it 
stimulates blood flow and decreases vascular resistance in skeletal muscle 
mediated in part by an endothelium dependant mechanism. Hypertension 
may therefore result due to an imbalance between the pressor and depressor 
action of insulin. 
Because of sodiwn retaining effects of insulin resistance with the associated 
hyperinsulinemia may be critical for the pathogenesis of salt .sensitivity in 
hypertension. The underlying mechanisms responsible for the coupling of 
insulin resistance/ hyperinsulinemia to the pathogenesis of hypertension still 
have to be understood (Ferrari et al 1991 ; Axelrod, 1991 ). 
26 
1.8. Current Perspectives 
Since none of the proposed mechanisms in the pathogenesis of 
hypertension have been established beyond doubt, it is necessary to provide 
evidence for and against the proposed relationships. 
Evidence in support: In the general population, blood pressure tends to 
correlate positively with plasma insulin levels. Young, overweight 
borderline hypertensive subjects tend to have higher fasting plasma insulin 
levels. Impaired insulin sensitivity as well as hyperinsulinemia was noted 
in some essential hypertensive patients even in the absence of obesity or 
diabetes mellitus (Ferrari et al, 1991). Insulin has been shown in short term 
studies to have multiple effects on the kidney, the sympathetic nervous 
system and cardiovascular system and sustained infusion could lead to 
hypertension (Weidmann et al, 1995). 
Evidence Against: The evidence marshalled against the role of 
hyperinsulinemia and insulin resistance in blood pressure regulation is that 
acute hyperinsulinemia in humans leads to vasodilation and a lowering of 
blood pressure rather than vasoconstriction. Chronic insulin infusion in dogs 
does not change blood pressure (Reaven, 1995). The acute effects of insulin 
on Na+ resabsorption may not be sufficient for chronic elevation of blood 
pressure or for the maintenance of increased sympathetic nervous system 
activity. Lastly, not all hypertensives are insulin resistant and not all insulin 
resistant subjects are hypertensive. 
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1.8.1 Selective Insulin Resistance 
Insulin promotes both blood flow and glucose extraction in insulin sensitive 
tissues . This vasodilatory response promotes insulins metabolic action by 
improving target tissue perfusion. Insulin resistance refers to a decreased 
insulin stimulated glucose disposal. Selective insulin resistance implies that 
while peripheral (muscle) tissue may become insensitive to insulins glucose 
lowering effects and there is resistance to insulin mediated skeletal muscle 
vasodilation, there will still be a preservation of renal and sympathetic 
nervous system sensitivity to insulin where the hormones action will still be 
unopposed (Heise et al, 1998). Excessive insulin induced effects may also 
possibly occur in tissues like the kidney where sensitivity to insulin is 
preserved (Sechi, 1999). 
This explains why insulin action on skeletal muscle vasodilation is blunted 
during insulin resistance. There is evidence to indicate that in obese and 
non-obese hypertensives insulin resistance is selective (predominantly 
involving glucose metabolism although amino acid and fatty acid metabolism 
can also be involved), tissue specific (predominantly affecting skeletal 
muscle, although liver, adipocytes and leucocytes may also be affected) and 
pathway specific (only glycogen synthesis is affected~ however during 
diabetic ketoacidosis all anabolic pathways are resistant to insulin effects) . 
Therefore in any individual or animal, the degree to which insulin resistance 
is tissue and pathway specific may determine whether hypertension will 
develop or not (Roccini, 1995). 
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1.8.2 Alternatives to Reaven's Hypothesis 
While the association between insulin resistance, hyperinsulinemia and 
hypertension is established but not totally explained, it is also theoretically 
possible that insulin resistance is secondary to structural changes in skeletal 
muscle caused by hypertension. Recent studies have also shown the blood 
pressure elevation could be mediated by insulin resistance rather than by 
hyperinsulinemia and that hypertriglyceridemia could also be causes of insulin 
resistance (Ferrannini et al 1997 ~ Heise et al 1998). However, evidence 
against insulin resistance and hyperinsulinemia being the consequence of 
hypertension is based on observations that the relationship between insulin 
and hypertension occurs both in humans and animals in primary hypertension 
and does not seem to occur during secondary hypertension (Sechi, 1999). 
1.9 Hypotheses relevant to the present study 
On the basis of available information,. the frequent occurrence of insulin 
resistance and hypertension may reflect three distinct possibilities. 
1. Insulin resistance and/or hyperinsulinemia, whatever the underlying 
mechanisms and time of appearance may cause and aggravate 
hypertension. 
2. Insulin resistance may occur as a secondary change during the develop-
ment of hypertension and may have no primary effect on the patho-
genesis of hypertension. 
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3. Insulin resistance and hypertension are inherited as separate states, 
are causally unrelated and may develop in parallel but independent 
manner. 
It must also be emphasised that blood pressure is controlled by an 
"orchestra" of neurohumoral, endocrine, metabolic and renal factors amongst 
which insulin may be but one "instrument" (Ferrari et al, 1991). 
Hyperinsulinemia, in contrast to catecholamines and angiotensin II does not 
acutely modify blood pressure. It may rather be representative of a "slow" 
pressor factor which compliments many other important mechanisms in the 
pathogenetic mosaic of hypertension (Weidmann et al, 1995). 
1.10 Animal Studies 
Experimental hypertensive rats are a widely used model in the investigation 
of the pathogenesis of human hypertension. There is evidence that 
resistance to insulin-induced glucose disposal and hyperinsulinemia exists in 
rat genetic models of hypertension such as the Zucker obese, the 
spontaneously hypertensive rat, the Milan hypertensive rat and the Dahl salt-
sensitive rat (Mondon and Reaven 1988; Reaven 1991 ; Kotchen et al, 1991; 
Reaven et al, 1991; Buchanan et al, 1992; Frontoni et al 1992). In 
genetically non-hypertensive rats, continuous high carbohydrate feeding 
results in hypertension that is also correlated to insulin resistance (Hwang et 
al, 1987; Reaven and Ho, 1991). Other studies have demonstrated that long 
term insulin administration in rats also leads to increased blood pressure 
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(Brands et al 1991; Meehan et al 1994). The insulin induced rise in blood 
pressure is reversed with the termination of insulin infusion indicating the 
specific effects of hyperinsulinemia (Hsieh et al, 1993). These observations 
provide direct support for the role of insulin resistance/hyperinsulinemia in 
the pathogenesis of hypertension in rats but like human studies, the precise 
mechanisms are not clearly established. 
Because insulin induced hypertension is absent in dogs, it is suggested that 
there may be important species - specific differences in the haemodynamic 
response to insulin (Brands et al, 1997). 
Insulin induced hypertension in rats shows two main features that are 
different from humans. Firstly, insulin induced hypertension is not associated 
with marked sodium retention. There is a shift in the pressure naturesis 
relation and the rats are in sodium balance at an elevated blo9d pressure. 
Total peripheral resistance rather than cardiac output is increased suggesting 
that there is an activation of a vasoconstrictor mechanism. In addition 
contrary to human studies it has been reported that insulin induced 
hypertension in rats is not sensitive to changes in sodium uptake (Hall et al, 
1992; Brands et al, 1997). 
1.10.1 The Salt Sensitive Dahl Rat • A Brief History 
Human essential hypertension is a classic example of a complex multifactorial 
and polygenic disease . Rat and mouse models of hypertension have been 
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developed by selective breeding over many generations . Their major 
advantages include complete genetic homogeneity, large numbers of 
offspring, the ability to produce large genetic crosses and to provide tight 
control over environmental influences (Dominiczak et al, 1988). In the 
l 960's Dr Lewis K Dahl and associates developed from the Sprague Dawley 
line two strains of rats that were either susceptible or resistant to the 
hypertensive effects of a high salt (8% NaCl) diet. In the 1970s John Rapp 
began systematic brother-sister matings of Dahl rats and in 1985 he described 
the development of fully inbred strains of Dahl Salt-Sensitive and Dahl Salt-
Resistant Rats . These were homozygous at 100% of all genetic loci, thus 
fixing the characteristics of the strain. These were termed the Dahl (SS/Jr) 
and Dahl (SR/Jr) respectively. Rapp provided these rats to Harlan Sprague 
Dawley, Inc (HSD Indianapolis, USA) in 1986 and since then multiple 
investigators have been provided with inbred Dahl/Rapp salt sensitive (SS/Jr 
Hsd) or salt resistant (SR/ Jr Hsd) animals for physiological, biochemical and 
genetic studies of salt-sensitive hypertension. The inbred Dahl/Rapp salt 
sensitive rat, hereafter referred to as the DSS rat, represent one of the best 
characterized and most widely studied models of low renin salt-sensitive 
hypertension (Lezin et al, 1994). 
1.10.2 Characteristics of the Dahl Salt-Sensitive Rat 
When the DSS rat is fed a high salt diet (8% NaCl), mean arterial pressure 
typically increases by 20 mm Hg within 24 hours and continues to rise to 
about 170 mm Hg or higher around two weeks. The initial rise in arterial 
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pressure appears to be triggered by sodium retention. The animal gains about 
7% in body weight and plasma volume and cardiac output increases 
significantly. Later, the cardiac output returns towards control values and the 
hypertension is maintained by increased peripheral resistance (Wilson et al, 
1998). In similarly treated Dahl salt resistant (DSR) rats, blood pressure 
remains in the normotensive range and the animals respond mildly if not at all 
to salt changes in the diet. 
The age at which a high salt diet is started partly determines the magnitude 
of the blood pressure response in DSS rats. When given a high salt diet at 
weaning (21-23 days of age) rats reach a mean blood pressure of 200 mm 
Hg within 6 weeks. If salt feeding is delayed until 3 months of age, the 
hypertension develops less rapidly and mean blood pressure reaches about 
185 mm Hg by 16-20 weeks. DSS rats do not become hypertensive when 
placed only on a high salt diet. In fact, on a normal rat diet that contains I% 
NaCl, DSS rats become markedly hypertensive but it takes a longer for the 
hypertension to develop. On low salt diets (0,3 to 0,4% NaCl) DSS rats 
often have pressures 15-20 mm Hg higher than DRS rats . Thus the absolute 
amount ofNa+in the diet is an important determinant of final blood pressure 
(Rapp, 1982). 
In DSS rats the rate of hypertension development is directly related to the 
daily salt intake. A 4% NaCl diet brings about 30% rise in blood pressure by 
the 11th week of feeding while in the same period the 8% NaCl diet induces 
a 70% rise in blood pressure (Dahl et al, 1968). This allows the DSS rat to 
serve as a model of hypertension which can be studied both in its acute and 
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chronic forms. DSS rats possess a genetic substratum in the form of a 
polygenic trait for the development of hypert~nsion. The environmental 
factor in the form of a high salt diet in turn accelerates and accentuates the 
production of the phenotype. 
1.10.3 Mechanism of Salt-Sensitive Hypertension in Dahl Rats 
The mechanism for the rise in blood pressure in the DSS rat has not yet been 
fully established and has been debated since the strain was first introduced. 
Renal, central nervous system mechanisms and various hormonal systems 
have been suggested to be responsible for the rise in blood pressure. Current 
literature attributes sodium induced hypertension to be due to genetic renal 
alterations that precede the development of hypertension. Under normal 
homeostatic conditions, when arterial pressure rises, the pressure-natriuretic 
mechanism operates as an infinite gain system and adjusts blood volume and 
cardiac output through increased urinary sodium and water excretion until 
arterial pressure returns to normal. Various studies on DSS rats have 
indicated that this pressure-natriuretic response is impaired or reset to a 
higher renal perfusion pressure, leading to sustained hypertension (Alvarez-
Guerra et al, 1998). DSS rats require a higher perfusion on pressure to 
achieve the same sodium excretion as a DSR rat. The resetting is largely due 
to a marked increase in Na+ and c1- reaborption in the thick ascending limb 
of the loop of Henle and a deficiency in the production of 20-hydroxyeicosa 
- 5,8,11 ,14-tetranoic acid (20 - HETE) which is a Na+, K+, 2c1- co-transporter 
inhibitor in this area of the nephron (Wilson et al, 1998). The kidney as a 
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source of one or more factors that induce hypertension in the Dahl and other 
genetically hypertensive rats is shown in studies demonstrating that 
hypertension can be transferred by renal transplantation from SHR rats to 
normotensive Wistar-Kyoto rats . Correspondingly, transplanting kidneys 
from normotensive to genetically hypertensive rats leads to a decrease in the 
hypertension of the recipients (Osswald et al, 1995). 
Neural mechanisms and humoral factors also contribute to the development 
of salt induced hypertension in Dahl S rats. A high salt intake can enhance 
sympathetic excitation and attenuate sympathetic inhibition. Arterial and 
cardiopulmonary baroreflex control of efferent sympathetic nerve activity are 
reported to be impaired in DSS rats . It is thought that increased ouabain-like 
activity in several brain areas during high salt intake could contribute to the 
development of hypertension (Huang and Leenen, 1998). 
With regards to humoral factors, the endogenous nitrovasodilator or L-
arginine: nitric oxide pathway plays an important role in the regulation of 
blood pressure and responses to changes in dietary salt. It has been shown 
that during salt overload, renal nitric oxide synthesis is impaired in the DSS 
rat thereby contributing to the hypertension via renal effects and via effects 
on vascular tone. Similarly, the vascular endothelin vasopressor system has 
also been implicated. During a high salt diet, vascular endothelin-1 (ET-1) 
levels are thought to increase, leading to potent local vasoconstriction and 
smooth muscle proliferation in blood vessels (Barton et al, 1998). 
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1.10.4 Components of the Insulin resistance syndrome in Dahl Rats 
Currently, the DSS rat is one of the best characterized and most widely 
studied model of genetic salt sensitive hypertension and is considered a 
good counterpart to human salt sensitive hypertension. There are various 
reports on insulin resistance occurring in genetic rat models of hypertension. 
Resistance to insulin induced glucose disposal has been reported in Zucker 
obese, DSS, Spontaneously Hypertensive rat (SHR) and the Milan 
hypertensive rat (Brands et al, 1991 ; Lembo et al, 1995; Kotchen, 1996). 
Exogenous insulin infusion has been reported to accelerate and aggravate the 
development of hypertension in the DSS rat (Tomiyama et al, 1992). When 
the euglycemic clamp technique was used to measure insulin sensitivity in the 
SHR and Milan hypertensive rat, hepatic and peripheral insulin sensitivity 
were found to be normal for both animal models (Frontoni et al, 1992). 
Similarly, the reports on Dahl rats being insulin resistant were based on 
surrogate measurements of insulin action like serum glucose and insulin 
determination in response to an oral glucose load or an in vitro method like 
glucose transport in isolated adipocytes (Kotchen et al, 1991 ; Reaven et al, 
1991 ). Apart from this, there have been no attempts to assessing the Dahl rat 
as a model for the insulin resistance syndrome as fashioned on the study by 
Vrana et al (1993); In this study inbred rat strains including the Hereditary 
hypertriglyceridemic (Htg), Brown Norway (BN), the SHR and the 
polydactyl-luxate syndrome carrying PD strain of Wistar origin were 
assessed for hypertriglyceridemia, impaired glucose tolerance, 
hyperinsulinemia, insulin resistance and hypertension. The Htg strain 
presented all the above symptoms of the insulin resistance syndrome. The 
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PD strain was normotensive while presenting all other symptoms. The SHR 
strain only showed the expected hypertension and only a mild increase in 
triglycerides and no changes in glucose tolerance. The shortcoming of the 
study was again that serum insulin and a oral glucose tolerance test rather 
than the euglycemic clamp technique was utilized used to assess insulin 
sensitivity. 
1.10.5 Molecular Mechanism of Insulin Resistance in Animal Models 
At receptor level, decreased sensitivity to insulin may occur due to defects 
in insulin binding, reduced receptor numbers, defects in signal transduction 
or modifications in the post receptor cascade (Selchi et al, 1996). 
The number of insulin receptors in target tissues is regulated by several 
different hormones and physiological conditions. A major factor that 
determines both insulin receptor number and gene expression is the ambient 
insulin concentration (homologous regulation) . In addition to insulin, other 
endocrine and metabolic factors such as glucagon, growth hormone, 
glucocorticoid and ketone concentrations may affect the insulin receptor 
number (heterologous regulation) (Kahn, 1983). 
Thus far only a few studies have addressed the molecular mechanisms of 
insulin resistance. Mondon et al (1989) found no difference in insulin 
receptor number or affinity in skeletal muscles of both SHR and Wistar 
Kyoto (WKY) rats . Another study demonstrated decreased 
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autophosphorylation of the insulin receptor and decreased phosphorylation 
of insulin receptor substrate IRS-I in liver and muscle of SHR compared 
with WKY rats (Kahn and Saad, 1992). Overall, these and other studies 
indicate the possible role of reduced insulin receptor kinase activity __ and 
reduced substrate phosphorylation in skeletal muscle and liver play a role in 
the insulin resistance of SHR (Setchi, 1999). 
1.10.6 Insulin Receptors, Salt Sensitivity and Insulin Resistance in 
Rat Models of Hypertension 
Sechi et al (1994) demonstrated an inverse relationship between dietary 
sodium intake and renal insulin receptor number and mRNA levels in 
Sprague-Dawley rats fed on low (0,07%), normal (0,3%) and high (7,5%) 
NaCl diets . This dose dependant relationship between salt intake and renal 
insulin receptor downregulation is mediated at the level of gene expression. 
Further, this observation suggested the existence of a feedback mechanism 
that limits insulin-induced sodium retention when extracellular fluid volume 
is expanded (Figure 4). 
In another study with SHR rats, which in addition to being hypertensive, are 
also insulin resistant ( Sechi et al, 1996) demonstrated that renal insulin 
receptor density and mRNA levels in the SHR do not differ from those of the 
WK Y when the rats are fed a low salt diet. A high salt diet decreases the 
receptor number and mRNA in WKY rats but not in the SHR. This is 
indicative of the SHR rats having lost t\le suggested feedback mechanism 
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that limits insulin induced sodium retention and further sodium retention may 
be implicated in the development and maintenance of hypertension in this 
model. 
In Dahl rats, Sechi et al, (1993) observed rio difference in tissue distribution, 
number and affinity of skeletal muscle and kidney insulin receptors in DSS 
and DSR rats fed different salt intakes. Binding parameters, hepatic, 
muscular and renal insulin receptor in m.RNA were also comparable in both 
groups at different salt intakes (Setchi et al, 1997). Therefore in Dahl rats, 
hypertension and the reported insulin resistance is associated with normal 
insulin receptor binding and gene expression in peripheral tissues and the 
decreased sensitivity may therefore be due to a post receptor defect and 
insulin-mediated sodium retention also appears to have no role in the salt 
sensitivity of the Dahl rat. 
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Figure 4: Representation of how insulin resistance might be linked to salt-sensitivity and hypertension 
(from Sechi, 1999) 
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1.11 Major Questions to be addressed by Study 
From the above review on Dahl rats, major questions that have to be 
addressed by this study are clarified below. 
1 . To what extent do the features of the insulin resistance syndrome 
establish themselves in the DSS rat model of genetic hypertension 
when fed a normal/ high salt diet? 
2. Is the DSS rat really insulin resistant when the "gold standard" for 
the measurement of insulin sensitivity is applied? 
3. Is insulin resistance related to blood pressure and salt intake in this 
model of genetic hypertension? 
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2. METHODS AND MATERIALS 
2.1. Introduction and Overview 
In order to attain the objectives put forth in the literature survey, the study 
design spans both the molecular/ cellular and integrative levels of 
physiological function. In the first phase of the study, termed Experiment 
1, biochemical parameters relating to the insulin resistance syndrome were 
determined in DSS and DSR rats on low and high sodium diets . The same 
parameters also measured in 2 additional matched 3 week old weanling DSS 
and DSR groups. 
In the second phase of the study, termed Experiment 2, the euglycemic 
glucose clamp technique was utilized to study in vivo glucose metabolism 
and insulin sensitivity in Wistar rats and in DSS and DSR rats fed normal and 
high salt diets. All experiments were approved by the Ethics Committee of 
the University of Durban-Westville. 
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Experiment 1: Table 1: Animals, groups and diets for Experiment 1 
Animal Groups DSS DRS DSS DRS WDSS WDSR 
(males) 
Numbers per group 8 8 8 8 8 8 
Diet (for 2 months) Low salt Low salt High salt High salt Weanlings Weanlings 
WDSS - Dahl Salt Sensitive weanlings, WDSR - Dahl Salt Resistant Weanlings 
1. Blood pressure measurements were made weekly for duration of diet. 
2. Urinary Na+ I K+ ratio, blood glucose, plasma insulin, plasma uric acid and a 
blood lipid profile were determined for all groups. 
3. Skeletal muscle insulin receptors were extracted and purified. 
4. Receptor insulin associated tyrosine kinase activity assayed for all groups. 
Experiment 2: Table 2: Animals, groups and diets for Experiment 2 
Animal Groups (males Wis tar DSR DSS DSR DSS 
and females) 
Number per group 12 males 6 males 6 males 3 males 3 males 
6 females 6 females 3 females 3 females 
Diet normal normal normal salt loaded salt loaded 
1. Determination of glucose metabolism and insulin sensitivity using 
euglycemic clamp for all groups 
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Experiment 1: 
2.2.1 Determination of Biochemical Parameters related to the Insulin 
Resistance Syndrome 
2.2.1 Animals and Diets 
Three weeks old male DSS and DSR rats were used. The parent colony were 
obtained from Harlan Sprague Dawley Inc (Indianapolis, USA). Eight rats 
from each group were fed a standard rat diet (60% carbohydrate~ 22% fat and 
18% protein) with low sodium (0,2% NaCl) and another 8 rats from each 
group were fed the same diet but with high sodium (4% NaCl). A 4% NaCl 
diet rather than a 8% diet was used to moderate blood pressure changes and 
avoid the development of renal damage that occurs with a 8% NaCl diet 
(Campbell et al, 1996). The feeding regimen for the high and low salt 
groups lasted 8 weeks with both food and distilled water available ad 
libitum. The 4 groups were housed 4 per cage at a constant temperature and 
exposed to a 12 hour light/dark cycle. 
2.2.2 Blood Pressure Measurement 
Body mass, systolic and diastolic blood pressure with the heart rate were 
measured weekly between 9h00 and l 2h00 for all animals with a widely 
used non-invasive computerized tail cuff method. (IITC, Model 31 , CA, 
USA). Before monitoring, rats were trained for 5 consecutive days with 
daily recording to minimize stress reactions. With measurement procedures 
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being non-invasive, the apparatus used was technically convenient for long 
term animal studies . 
2.2.2.1 Operation Principle 
The system employed an automatic scanner, a pump, a tail cuff with a 
photoelectric sensor and an amplifier, to measure and count the heart pulses 
in the animal's tail. The principle of operation is related to the Riva-Rocci 
method used in humans. Conscious, unanaesthetised animals were placed in 
a perspex restrainer and the pump automatically inflated the tail cuff placed 
at the base of the rat tail. This results in arterial blood supply to the tail be 
occluded. The cuff was then deflated and the reappearance of pulsations, as 
detected by the photoelectric sensor, was taken as the systolic blood 
pressure. As the pressure continued to fall , the computer stored the value of 
each high pulse point which was accepted as a mean pressure if there was 
no higher pulse within the next two seconds . The diastolic pressure for the 
recording was computed using the equation: diastolic= (3 mean - systolic)/2. 
The test results were displayed as data plots and summaries on the computer 
screen (Figure 5). The test information has 2 tracings - one showing the 
pressure applied to the sensing cuff and the other shows the pulse detected 
by the sensor. The systolic, mean and calculated diastolic blood pressures 
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FIGURE 5: A typical rat tail pulse recording using the llTC blood 
pressure monitor. 
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